These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 39413160)

  • 1. Human OX40L-CAR-T
    Rui X; Alvarez Calderon F; Wobma H; Gerdemann U; Albanese A; Cagnin L; McGuckin C; Michaelis KA; Naqvi K; Blazar BR; Tkachev V; Kean LS
    Sci Transl Med; 2024 Oct; 16(769):eadj9331. PubMed ID: 39413160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OX40L/OX40 axis impairs follicular and natural Treg function in human SLE.
    Jacquemin C; Augusto JF; Scherlinger M; Gensous N; Forcade E; Douchet I; Levionnois E; Richez C; Lazaro E; Duffau P; Truchetet ME; Seneschal J; Couzi L; Pellegrin JL; Viallard JF; Schaeverbeke T; Pascual V; Contin-Bordes C; Blanco P
    JCI Insight; 2018 Dec; 3(24):. PubMed ID: 30568041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OX40L-JAG1-Induced Expansion of Lineage-Stable Regulatory T Cells Involves Noncanonical NF-κB Signaling.
    Kumar P; Lele SS; Ragothaman VK; Raghunathan D; Epstein AL; Chiba S; Prabhakar BS
    J Immunol; 2019 Dec; 203(12):3225-3236. PubMed ID: 31704879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chimeric antigen receptor costimulation domains modulate human regulatory T cell function.
    Boroughs AC; Larson RC; Choi BD; Bouffard AA; Riley LS; Schiferle E; Kulkarni AS; Cetrulo CL; Ting D; Blazar BR; Demehri S; Maus MV
    JCI Insight; 2019 Mar; 5(8):. PubMed ID: 30869654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Supraphysiological FOXP3 expression in human CAR-Tregs results in improved stability, efficacy, and safety of CAR-Treg products for clinical application.
    Henschel P; Landwehr-Kenzel S; Engels N; Schienke A; Kremer J; Riet T; Redel N; Iordanidis K; Saetzler V; John K; Heider M; Hardtke-Wolenski M; Wedemeyer H; Jaeckel E; Noyan F
    J Autoimmun; 2023 Jul; 138():103057. PubMed ID: 37224732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OX40L/Jagged1 cosignaling by GM-CSF-induced bone marrow-derived dendritic cells is required for the expansion of functional regulatory T cells.
    Gopisetty A; Bhattacharya P; Haddad C; Bruno JC; Vasu C; Miele L; Prabhakar BS
    J Immunol; 2013 Jun; 190(11):5516-25. PubMed ID: 23630352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble OX40L and JAG1 Induce Selective Proliferation of Functional Regulatory T-Cells Independent of canonical TCR signaling.
    Kumar P; Alharshawi K; Bhattacharya P; Marinelarena A; Haddad C; Sun Z; Chiba S; Epstein AL; Prabhakar BS
    Sci Rep; 2017 Jan; 7():39751. PubMed ID: 28045060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human CD8+ Tregs expressing a MHC-specific CAR display enhanced suppression of human skin rejection and GVHD in NSG mice.
    Bézie S; Charreau B; Vimond N; Lasselin J; Gérard N; Nerrière-Daguin V; Bellier-Waast F; Duteille F; Anegon I; Guillonneau C
    Blood Adv; 2019 Nov; 3(22):3522-3538. PubMed ID: 31730699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined OX40L and mTOR blockade controls effector T cell activation while preserving T
    Tkachev V; Furlan SN; Watkins B; Hunt DJ; Zheng HB; Panoskaltsis-Mortari A; Betz K; Brown M; Schell JB; Zeleski K; Yu A; Kirby I; Cooley S; Miller JS; Blazar BR; Casson D; Bland-Ward P; Kean LS
    Sci Transl Med; 2017 Sep; 9(408):. PubMed ID: 28931653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OX40, OX40L and Autoimmunity: a Comprehensive Review.
    Webb GJ; Hirschfield GM; Lane PJ
    Clin Rev Allergy Immunol; 2016 Jun; 50(3):312-32. PubMed ID: 26215166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD19-targeted CAR regulatory T cells suppress B cell pathology without GvHD.
    Imura Y; Ando M; Kondo T; Ito M; Yoshimura A
    JCI Insight; 2020 Jul; 5(14):. PubMed ID: 32525846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chimeric Antigen Receptor (CAR) Treg: A Promising Approach to Inducing Immunological Tolerance.
    Zhang Q; Lu W; Liang CL; Chen Y; Liu H; Qiu F; Dai Z
    Front Immunol; 2018; 9():2359. PubMed ID: 30369931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD40 Activity on Mesenchymal Cells Negatively Regulates OX40L to Maintain Bone Marrow Immune Homeostasis Under Stress Conditions.
    Bassani B; Tripodo C; Portararo P; Gulino A; Botti L; Chiodoni C; Jachetti E; Bolli N; Ciciarello M; Joehrens K; Anagnostopoulos I; Na IK; Curti A; Colombo MP; Sangaletti S
    Front Immunol; 2021; 12():662048. PubMed ID: 34084166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-A*02:01-directed chimeric antigen receptor/forkhead box P3-engineered CD4+ T cells adopt a regulatory phenotype and suppress established graft-versus-host disease.
    Martin A; Daris M; Johnston JA; Cui J
    Cytotherapy; 2021 Feb; 23(2):131-136. PubMed ID: 33309258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical role of OX40 signaling in the TCR-independent phase of human and murine thymic Treg generation.
    Kumar P; Marinelarena A; Raghunathan D; Ragothaman VK; Saini S; Bhattacharya P; Fan J; Epstein AL; Maker AV; Prabhakar BS
    Cell Mol Immunol; 2019 Feb; 16(2):138-153. PubMed ID: 29578532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precision Engineering of an Anti-HLA-A2 Chimeric Antigen Receptor in Regulatory T Cells for Transplant Immune Tolerance.
    Muller YD; Ferreira LMR; Ronin E; Ho P; Nguyen V; Faleo G; Zhou Y; Lee K; Leung KK; Skartsis N; Kaul AM; Mulder A; Claas FHJ; Wells JA; Bluestone JA; Tang Q
    Front Immunol; 2021; 12():686439. PubMed ID: 34616392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treg-expressed CTLA-4 depletes CD80/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells.
    Tekguc M; Wing JB; Osaki M; Long J; Sakaguchi S
    Proc Natl Acad Sci U S A; 2021 Jul; 118(30):. PubMed ID: 34301886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of a Chimeric Antigen Receptor Specific for Donor HLA Class I Enhances the Potency of Human Regulatory T Cells in Preventing Human Skin Transplant Rejection.
    Boardman DA; Philippeos C; Fruhwirth GO; Ibrahim MA; Hannen RF; Cooper D; Marelli-Berg FM; Watt FM; Lechler RI; Maher J; Smyth LA; Lombardi G
    Am J Transplant; 2017 Apr; 17(4):931-943. PubMed ID: 28027623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Umbilical cord blood regulatory T-cell expansion and functional effects of tumor necrosis factor receptor family members OX40 and 4-1BB expressed on artificial antigen-presenting cells.
    Hippen KL; Harker-Murray P; Porter SB; Merkel SC; Londer A; Taylor DK; Bina M; Panoskaltsis-Mortari A; Rubinstein P; Van Rooijen N; Golovina TN; Suhoski MM; Miller JS; Wagner JE; June CH; Riley JL; Blazar BR
    Blood; 2008 Oct; 112(7):2847-57. PubMed ID: 18645038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineered regulatory T cells expressing myelin-specific chimeric antigen receptors suppress EAE progression.
    De Paula Pohl A; Schmidt A; Zhang AH; Maldonado T; Königs C; Scott DW
    Cell Immunol; 2020 Dec; 358():104222. PubMed ID: 33053469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.